Study period | ||||
Enrolment | Allocation | Postallocation | Close-out | |
Timepoint (days) | 0 | 0 | 0 to 28 maximum | 28 maximum |
Enrolment | ||||
Eligibility screen | X | |||
Express consent | X | |||
Allocation | X | |||
Interventions | ||||
HFHO | X | |||
Standard O2 | X | |||
Assessments | ||||
Baseline variables | ||||
Demographics | X | |||
Medical history | X | |||
Clinical examination | X | |||
Paraclinical examination (pH, SOFA score) SAPS II score ECG–chest X-ray) ACRF aetiology | X | |||
Outcomes variables | ||||
NIV duration | X | |||
HFHO or standard O2 duration according to group allocation | X | |||
Intubation/reintubation | X | |||
Vital status | X | X | ||
VAS comfort after 1 hour of NIV resumption | X | |||
VAS dyspnoea after 1 hour of NIV resumption | X | |||
Likert scale for comfort after 1 hour of NIV resumption | X | |||
Likert scale for dyspnoea after 1 hour of NIV resumption | X | |||
VAS comfort after 2 hours of SB resumption* | X | |||
VAS dyspnoea after 2 hours of SB resumption* | X | |||
Likert scale for comfort after 2 hours of SB resumption* | X | |||
Likert scale for dyspnoea after 2 hours of SB resumption* | X | |||
Respiratory rate after 1 hour of NIV resumption | X | |||
Respiratory rate after 2 hours of SB resumption* | X | |||
Daily ABG | X | |||
Adverse events | X | |||
Hospital length of stay | X | |||
Other variables | ||||
Criteria for switching between NIV and SB | X | |||
Criteria to definitely stop NIV | X | |||
Criteria for intubation | X | |||
Discharge conditions | X |
*Two hours of SB in the first 48 hours postrandomisation, and 4 hours thereafter.
ABG, arterial blood gas; ACRF, acute-on-chronic respiratory failure; HFHO, high flow heated and humidified nasal oxygen; NIV, non-invasive ventilation; SAPS II, simplified acute physiology score II; SB, spontaneous breathing; SOFA, sequential organ failure assessment; VAS, Visual Analogue Scale.